Denise Moore
Primary Care · West Hollywood, CANPI 1326414756
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 33 manufacturers, the largest accounting for just 11.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $868, 4.3 times the $200 reported in 2021. Among primary care clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 113 payments — averaging $30.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$385
- Lilly USA, LLC$315
- Amgen$302
- Novo Nordisk$257
- Biohaven Pharmaceutical Holding Company Ltd.$166
- Bayer$156
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,473100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 13 | $385 |
| Lilly USA, LLC | 12 | $315 |
| Amgen | 10 | $302 |
| Novo Nordisk | 8 | $257 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $166 |
| Bayer | 7 | $156 |
| Edwards Lifesciences | 1 | $150 |
| AstraZeneca | 6 | $144 |
| Gilead | 5 | $143 |
| GSK | 5 | $134 |
| Lundbeck LLC | 1 | $125 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $124 |
| Novartis | 4 | $97 |
| Pfizer | 3 | $94 |
| Boehringer Ingelheim | 3 | $93 |
| Cleerly, Inc. | 2 | $91 |
| Kowa Pharmaceuticals America, Inc. | 4 | $82 |
| Scynexis, Inc. | 1 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $70 |
| Idorsia Pharmaceuticals US Inc | 2 | $47 |
| Viiv Healthcare Company | 1 | $35 |
| Ironwood Pharmaceuticals, Inc | 1 | $30 |
| Heartflow, Inc. | 1 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $30 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| IBSA Pharma Inc. | 1 | $25 |
| Esperion Therapeutics, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $24 |
| Exact Sciences | 1 | $24 |
| Amarin Pharma, Inc. | 1 | $22 |
| Linus Health, Inc. | 1 | $20 |
| Genentech USA, Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Edwards SAPIEN 3 Transcatheter Heart Valve$150
- Repatha$131
- VYEPTI$125
- JYNARQUE$125
- QULIPTA$123
How this compares
$3,473 in reported general payments places this provider in the 90th percentile of 706 primary care providers in California.
Other primary care in West Hollywood
- Leslie FletcherTorrance$1.8M
- Hamideh PourzandLos Angeles$103K
- Veronica RamirezSacramento$83K
- Tyson FieldstedBakersfield$65K
- Kathryn CooperSan Diego$31K
- Shalaine Corbillala Mesa$22K
- Paula StoddardHanford$22K
- Ashley LoweSan Diego$19K
- Vanessa LeeLong Beach$16K
- Lynda TranHuntington Beach$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.